|
| | HR0516 | | LRB102 21089 MST 30057 r |
|
|
1 | | HOUSE RESOLUTION
|
2 | | WHEREAS, Forty-five percent of Americans have used a |
3 | | prescription drug in the past 30 days in the United States; and
|
4 | | WHEREAS, Millions of Americans rely on copay assistance |
5 | | programs to afford their prescription drugs; and
|
6 | | WHEREAS, On average, cost-sharing assistance helped |
7 | | patients taking HIV or oncology medicines with more than |
8 | | $1,600 toward their out-of-pocket cost in 2019 and helped |
9 | | patients taking multiple sclerosis medicines with more than |
10 | | $2,200; and
|
11 | | WHEREAS, When copay accumulator adjustment programs |
12 | | prevent any copayment assistance from counting toward a |
13 | | member's deductible or maximum out-of-pocket requirements, the |
14 | | result is that patients may be left with insurmountably high |
15 | | out-of-pocket expenses for their medications; and
|
16 | | WHEREAS, Patients with chronic and rare diseases are |
17 | | particularly impacted and struggle to afford their specialty |
18 | | medications; and
|
19 | | WHEREAS, Copay accumulator adjustment programs coupled |
20 | | with the rise of patient out-of-pocket expenses resulting from |
|
| | HR0516 | - 2 - | LRB102 21089 MST 30057 r |
|
|
1 | | increased deductibles and co-insurance, accounting for up to |
2 | | 95 percent of patients costs for brand medicines, leads to |
3 | | patient medication nonadherence; and
|
4 | | WHEREAS, Medication nonadherence has led to between $100 |
5 | | and $300 billion of avoidable health care costs in the United |
6 | | States annually, due to avoidable hospitalizations and medical |
7 | | visits; and
|
8 | | WHEREAS, The State of Illinois passed Public Act 101-0452 |
9 | | (215 ILCS 134/30(d)) to eliminate the burden patients face due |
10 | | to copay accumulator programs; and
|
11 | | WHEREAS, Public Act 101-0452 passed the Illinois General |
12 | | Assembly with unanimous support; and
|
13 | | WHEREAS, The law ensures that a health care plan shall |
14 | | apply any third-party payments, financial assistance, |
15 | | discount, product vouchers, or any other reduction in |
16 | | out-of-pocket expenses made by or on behalf of such insured |
17 | | for prescription drugs toward a covered individual's |
18 | | deductible, copay, or cost-sharing responsibility or |
19 | | out-of-pocket maximum associated with the individual's health |
20 | | insurance; and
|
21 | | WHEREAS, The lack of clarity between federal and state |
|
| | HR0516 | - 3 - | LRB102 21089 MST 30057 r |
|
|
1 | | laws and regulations has left consumers in a vulnerable |
2 | | position; therefore, be it
|
3 | | RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE ONE |
4 | | HUNDRED SECOND GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that |
5 | | we declare our commitment to ensuring access to quality health |
6 | | care for patients and healthcare consumers in Illinois; and be |
7 | | it further
|
8 | | RESOLVED, That we urge the Illinois Congressional |
9 | | Delegation to support federal legislation to ensure all copays |
10 | | count and urge the federal regulators to specifically clarify |
11 | | that all copays count in the 2023 Notice of Benefit and Payment |
12 | | Parameters and tri-agency guidance; and be it further
|
13 | | RESOLVED, That suitable copies of this resolution be |
14 | | delivered to the Governor, the Director of the Illinois |
15 | | Department of Insurance, all Illinois constitutional officers, |
16 | | and all members of the Illinois Congressional Delegation in |
17 | | order to bring further awareness to the importance of access |
18 | | to healthcare for our residents of the State of Illinois and to |
19 | | be a model state for the rest of the country.
|